Skip to main content

Table 4 The effects of sex × neopterin on tryptophan, KP metabolites and the KA/QA ratio

From: Sex-specific associations of kynurenic acid with neopterin in Alzheimer’s disease

 

Trp

Kyn

KA

AA

3-HK

Pic

QA

KA/QA

A. Whole cohort

 Diagnoses

-0.09

0.12

0.28*

-0.23*

0.05

0.22*

0.01

0.30*

 Age

0.06

0.15*

0.17*

0.17*

0.11

-0.02

0.32*

0.08

 Sex

0.18*

0.15*

0.03

-0.10

0.09

0.24*

0.19*

-0.02

APOE ɛ4 genotype

0.01

-0.09

-0.03

0.04

0.04

-0.01

0.00

-0.02

 Amyloid-β42

-0.02

0.02

-0.06

0.08

0.01

-0.06

0.00

-0.06

 P-tau181

-0.02

-0.10

0.17*

-0.05

-0.03

0.07

-0.05

0.20*

 Neopterin (log10)

0.07

0.47*

0.39*

0.08

0.20*

0.05

0.40*

0.30*

 Neopterin x sex

0.09

0.00

-0.16

-0.05

-0.01

0.05

0.01

-0.19*

 Adjusted R2

0.07

0.29

0.20

0.08

0.05

0.07

0.39

0.14

B. AD

 Age

0.02

0.08

0.12

0.12

0.14

-0.03

0.30*

0.03

 Sex

0.16*

0.14*

0.01

-0.13

0.05

0.27*

0.20*

-0.06

 Amyloid-β42

0.09

-0.03

0.00

-0.13

0.00

-0.03

0.00

-0.01

 P-tau181

0.04

-0.13

0.20*

-0.15

-0.05

0.03

-0.07

0.24*

 Neopterin (log10)

0.09

0.50*

0.48*

0.16

0.23*

0.02

0.44*

0.37*

 Neopterin x sex

0.00

-0.05

-0.22*

-0.04

-0.05

0.07

-0.07

-0.23*

 Adjusted R2

0.03

0.26

0.24

0.06

0.05

0.06

0.36

0.15

C. CU

 Age

0.22

0.25*

0.31*

0.21

-0.08

0.00

0.29*

0.22

 Sex

0.11

-0.16

0.12

-0.15

0.15

0.14

0.14

0.11

 Amyloid-β42

0.04

-0.04

0.20

0.00

0.02

0.09

-0.01

0.21

 P-tau181

-0.24*

-0.17

0.08

-0.11

-0.02

-0.01

0.00

0.09

 Neopterin (log10)

0.00

0.34

0.16

-0.15

0.21

0.09

0.24

0.13

 Neopterin x sex

0.31

0.10

-0.13

0.09

0.20

0.02

0.22

-0.23

 Adjusted R2

0.21

0.31

0.13

-0.01

0.10

-0.02

0.37

0.06

  1. *P < .01. significant associations in bold. Standardized β- coefficients are presented. Diagnoses: CU controls = 0, AD = 1; APOE ɛ4 genotype: neg = 0, pos = 1; Whole cohort (A): Amyloid-β42 and P-tau181 dichotomized according to laboratory-specific cut-off values: normal = 1, pathological = 2; AD patients (B) and CU controls (C): Amyloid-β42 and P-tau181 as continuous variables. Abbreviations: 3-HK 3-hydroxykynurenine, AA anthranilic acid, AD Alzheimer’s disease, CU cognitively unimpaired, KA kynurenic acid, Kyn kynurenine, Pic picolinic acid, Trp trypthophan, QA quinolinic acid